ESC Premium Access

From clinical evidence to patient management- How to reverse DOAC in clinical practice .

Topic: Pharmacology and Pharmacotherapy, Other
Sponsored by Portola Pharmaceutials Inc.

Presentation

About the speaker

Professor Saskia Middeldorp

Amsterdam UMC - Location VUmc, Amsterdam (Netherlands (The))
3 presentations
0 follower

4 more presentations in this session

Introduction and welcome

Speaker: Doctor E. Lerkevang Grove (Aarhus, DK)

Thumbnail

DOAC-related bleeding: demographics, risk factors & guidelines .

Speaker: Professor J. Oldgren (Uppsala, SE)

Thumbnail

Specific reversal agent for FXa - Inhibitor treatment - What the study data reveals? .

Speaker: Doctor A. Cohen (London, GB)

Thumbnail

Plenary questions and discussion

Speaker: Professor E. Lindhoff-Last (DE) Doctor E. Lerkevang Grove (Aarhus, DK)

Thumbnail

Access the full session

Paradigm shift in DOAC reversal - What are the current therapeutic options?

Speakers: Professor S. Middeldorp, Doctor E. Lerkevang Grove, Professor J. Oldgren, Doctor A. Cohen, Professor E. Lindhoff-Last...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk